Anzeige
Mehr »
Dienstag, 20.01.2026 - Börsentäglich über 12.000 News
98,7% Goldausbeute ohne Cyanid - kommt jetzt der Milliarden-Deal?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JDMF | ISIN: US75062E1064 | Ticker-Symbol:
NASDAQ
20.01.26 | 16:10
1,240 US-Dollar
-0,40 % -0,005
Branche
Immobilien
Aktienmarkt
Sonstige
1-Jahres-Chart
RAFAEL HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
RAFAEL HOLDINGS INC 5-Tage-Chart

Aktuelle News zur RAFAEL HOLDINGS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12.12.25Rafael Holdings, Inc. - 10-Q, Quarterly Report7
11.12.25Rafael Holdings, Inc.: Rafael Holdings Reports First Quarter Fiscal 2026 Financial Results132NEWARK, N.J., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL) today reported its financial results for the first quarter fiscal year 2026 ended October 31, 2025. "We remain pleased...
► Artikel lesen
11.12.25Rafael Holdings GAAP EPS of $0.19, revenue of $0.24M3
RAFAEL HOLDINGS Aktie jetzt für 0€ handeln
11.12.25Rafael Holdings, Inc. - 8-K, Current Report-
11.12.25NSE - Rafael Holdings, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities-
02.12.25Rafael Holdings gibt im Zuge der Fusion mit Cyclo Therapeutics Optionsscheine aus7
02.12.25Rafael Holdings, Inc. - 8-K, Current Report-
29.10.25Rafael Holdings GAAP EPS of -$0.28, revenue of $0.35M1
29.10.25Rafael Holdings, Inc. - 10-K, Annual Report1
29.10.25Rafael Holdings, Inc.: Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results167Cyclo Therapeutics' TransportNPC Phase 3 clinical trial for Trappsol® Cyclo for the treatment of Niemann-Pick Disease Type C1, a rare and fatal genetic disease, is continuing at the recommendation...
► Artikel lesen
28.10.25Rafael Holdings, Inc. - 8-K, Current Report1
28.10.25Rafael Holdings, Inc.: Rafael Holdings Mourns the Passing of Lead Independent Director, Stephen Greenberg, and Announces the Appointment of Alan Grayson to its Board of Directors160NEWARK, N.J., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT) sadly announced today the passing of its Lead Independent Director, Stephen Greenberg, and...
► Artikel lesen
10.10.25Rafael Holdings, Inc. - 8-K, Current Report1
16.09.25Rafael Holdings, Inc.: Rafael Holdings Announces Presentation of Preliminary Data from Ongoing Phase 3 TransportNPC Open-Label, Single-Arm Sub-Study in Patients Less Than 3 Years Old8
27.08.25Rafael Holdings, Inc.: Rafael Holdings Announces Abstracts Accepted for Oral and Poster Presentations at the 15th International Congress of Inborn Errors of Metabolism (ICIEM)3
07.08.25Rafael Holdings, Inc. - 8-K, Current Report3
18.06.25Rafael Holdings, Inc.: Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Disease Type C1 (NPC1) Following Independent Data Monitoring Committee (DMC) Review of Prespecified 48-Week ...274Phase 3 TransportNPC study to continue based on the independent DMC review of safety and efficacy data at prespecified 48-week interim analysis Data on the investigational candidate Trappsol® Cyclo...
► Artikel lesen
04.06.25Rafael Holdings, Inc. Announces Final Results and Closing of Rights Offering364NEWARK, N.J., June 04, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT) announced today the final results and closing of its $25.0 million rights offering (the "Rights...
► Artikel lesen
26.03.25Rafael Holdings, Inc.: Rafael Holdings Completes Merger with Cyclo Therapeutics Following Shareholder Approvals347NEWARK, N.J. and GAINESVILLE, Fla., March 26, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL), and Cyclo Therapeutics, Inc. (NASDAQ: CYTH) today announced the closing of their business...
► Artikel lesen
13.03.25Rafael Holdings, Inc.: Rafael Holdings Reports Second Quarter Fiscal 2025 Financial Results238The planned merger with Cyclo Therapeutics is anticipated to close in Q3 pending shareholder approvals Post-merger the Company intends to focus its efforts on Cyclo's lead clinical program Trappsol®...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1